key: cord-0328823-23ns7h72 authors: Jennewein, Madeleine F.; Kosikova, Martina; Noelette, Francesca J.; Radvak, Peter; Boudreau, Carolyn M.; Campbell, James D.; Chen, Wilbur H.; Xie, Hang; Alter, Galit; Pasetti, Marcela F. title: Functional and structural modifications of influenza antibodies during pregnancy date: 2021-05-18 journal: bioRxiv DOI: 10.1101/2021.05.18.444722 sha: 620692cb107e482cf9be43415a2b3b281356dd03 doc_id: 328823 cord_uid: 23ns7h72 Pregnancy represents a unique tolerogenic immune state which may alter susceptibility to infection and vaccine-response. Here we characterized humoral immunity to seasonal influenza vaccine strains in pregnant and non-pregnant women. Pregnant women had reduced hemagglutinin subtype-1 (H1)-IgG, IgG1, and IgG2, hemagglutination inhibition and group 1 and 2 stem IgG. However, H1-specific avidity and FcγR1 binding increased. Influenza-antibodies in pregnancy had distinct Fc and Fab glycans characterized by di-galactosylation and di-sialylation. In contrast, agalactosylation and bisection were prominent outside of pregnancy. H1-specific Fc-functionality was moderately reduced in pregnancy, although likely compensated by stronger binding to cognate antigen and FcR. Multivariate analysis revealed distinct populations characterized by FcγR1 binding, H1-IgG levels, and glycosylation. Pooled sera from pregnant women exhibited longer retention in vivo. Our results demonstrate structural and functional modulation of humoral immunity during pregnancy in an antigen-specific manner towards reduced inflammation, increased retention in circulation, and efficient placental transport. The immune system adapts in a precise and unique way during pregnancy to support fetal 36 development and facilitate full-term delivery. These adaptations involve changes in cell phenotypes and 37 frequencies (Th2 polarization, reduction of circulating NK and T cells, reduction in the number of B 38 cells) as well as modulation of cell function (i.e., cytokine production) ( There is a long history of safe and effective immunization of pregnant women against tetanus 52 and diphtheria (Forsyth et al. 2015) . In the past decade, the introduction of maternal acellular pertussis Table 1 ). The breadth of antibody responses was determined through analysis of full-length HA-and HA- Pregnant women had significantly lower IgG titers against H1 MI HA, as compared to the non-104 pregnant, while titers against H1 CA were unaffected ( Figure 1A) . A trend of lower H3-IgG was also 105 observed ( Figure 1A) . Serum IgG directed to the conserved group 1 and group 2 stem regions were 106 both substantially reduced in the pregnant women ( Figure 1B ). Although both groups had similar HAI 107 and MN titers for the contemporary vaccine strains H1 MI and H3 HK ( Figure 1C, D) , pregnant women 108 did exhibit significantly reduced HAI titers against the original pandemic strain H1 CA ( Figure 1C ). Intriguingly, the avidity of IgG against H1 CA HA was higher in the pregnant women as compared to 110 the non-pregnant ( Figure 1E ). Likewise, a trend of higher IgG avidity against H1 MI HA was observed. Together, these results hint at pregnancy-associated differences in magnitude, canonical functions, and 112 strength of binding of influenza antibodies, which appear to be antigen-specific. To better understand the profile of influenza-specific antibodies elicited during pregnancy, we 116 conducted a detailed class (IgG, IgA, and IgM) and subclass (IgG 1-4 and IgA (1-2) analysis of serum 117 antibodies specific for full-length Has H1 MI and H3 HK and their binding capacity to different Fc 118 receptors using a multiplex luminex assay (Figure 2) . Consistent with the ELISA data described above 119 ( Figure 1A) , pregnant women had significantly reduced levels of H1 MI HA-specific total IgG, IgG1, 120 IgG2, and IgG3 as compared to non-pregnant women (Figure 2A, B) . A similar trend of lower antibody 121 levels (as seen previously by ELISA, in Figure 2 ) remained for H3 HA-specific IgG and IgG1, and no 122 differences were seen in either H1 MI or H3 HA-specific IgA1, IgA2, or IgM levels between the two 123 groups (Figure 2A, B) . Pregnant women had a significantly lower ratio of IgG1 and IgG3 to IgG4 for Clear differences were also seen in terms of HA antibody binding to Fc-receptors between the To identify pregnancy-associated changes in influenza-specific antibody glycosylation, we 134 examined the Fc-and Fab-glycan composition of total and H1 MI-and H3 HK-specific serum IgG in 135 both pregnant and non-pregnant women. For each of the samples, a total of 24 distinct glycan peaks 136 were captured by capillary electrophoresis, and overall changes in the four differentially added sugars 137 (galactose, sialic acid, bisecting n-acetyl glucosamine-GlcNAc-and fucose) were calculated for bulk 138 ( Figure 3A , B) and HA-specific (Figure 3C -F, G-V) IgG for each group. Compared to bulk IgG of non-pregnant women, the bulk Fc glycosylation profile of pregnant women 140 revealed shifts towards increased fucosylation (F) and sialylation (S1 and S2) consistent with an anti- Both H1 HA-and H3 HA-specific antibodies in the pregnant group exhibited reduced cytotoxicity 163 (ADCC) although it did not reach statistical significance ( Figure 4F ). Overall, a consistent trend towards 164 reduced antibody functionality across FcR-dependent functions was observed in the pregnant women. The predominant changes on H1 HA-specific antibody function further supports pregnancy-associated 166 impact on antigen-specific humoral immunity. In addition to lower IgG response to the H1 vaccine strain, pregnant women had reduced IgG 238 titers against highly conserved group 1 and group 2 HA stem regions. This observation is new and 239 suggests that production of stem-specific antibodies during pregnancy might be impaired and that these Antibody glycosylation for HA-specific and bulk antibodies was analyzed by capillary electrophoresis. Recommended composition of influenza virus vaccines for use in 594 the 2017-2018 northern hemisphere influenza season Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid Acellular Pertussis Vaccine (Tdap) in Pregnant Women A robust, high-throughput assay 600 to determine the phagocytic activity of clinical antibody samples Influenza Vaccination During Pregnancy' H3N2 influenza viruses in humans: Viral mechanisms, evolution, 604 and evaluation 606 'Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc COVID-610 19: neonatal-perinatal perspectives Altered response to A(H1N1)pnd09 vaccination in pregnant 613 women: a single blinded randomized controlled trial Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric 616 high-throughput profiling method reveals pregnancy-associated changes Association between galactosylation of immunoglobulin G and improvement of rheumatoid 620 arthritis during pregnancy is independent of sialylation Fab glycosylation of 622 immunoglobulin G does not associate with improvement of rheumatoid arthritis during pregnancy High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples Sweet SIGNs: IgG glycosylation 628 leads the way in IVIG-mediated resolution of inflammation 630 'Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG 631 subclasses Comparison of the Fc glycosylation of fetal and maternal 634 immunoglobulin G' Maternal vaccination: 636 moving the science forward Prevention and 639 control of influenza with vaccines: recommendations of the Advisory Committee on Immunization 640 Practices (ACIP) A 642 high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce 643 complement activation Strategies to decrease pertussis 645 transmission to infants Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory 648 Committee on Immunization Practices -United States Modulating Antibody Functionality in Infectious Disease and 651 Vaccination' IgG subclass profiles in normal 653 human sera of antibodies specific to five kinds of microbial antigens Humoral and cell 655 mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women', 656 Vaccine Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model H1N1 2009 influenza virus 664 infection during pregnancy in the USA Pregnancy-associated serum N-glycome changes studied by high-667 throughput MALDI-TOF-MS Fc Glycan-Mediated Regulation of Placental Antibody Transfer A versatile high-throughput assay to characterize antibody-674 mediated neutrophil phagocytosis Imprinting of Repeated Influenza 676 Implications for Seasonal Vaccine Strain 677 Selection and Vaccine Performance Pregnancy and infection Characterizing the pregnancy immune 682 phenotype: results of the viral immunity and pregnancy (VIP) study Peripheral blood cytokine profiling during pregnancy and 685 post-partum periods Honein, and Group California Pandemic Working. 2010. 687 'Severe 2009 H1N1 influenza in pregnant and postpartum women in California Fc 691 Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women 693 Influenza Other Respir Viruses Should yellow fever vaccine be included in the expanded 695 program of immunization in Africa? A cost-effectiveness analysis for Nigeria The immune system in pregnancy: a unique complexity Safety and immunogenicity of three seasonal inactivated influenza 701 vaccines among pregnant women and antibody persistence in their infants 704 'Protective Effect of Maternal Influenza Vaccination on Influenza in Their Infants: A Prospective Cohort 705 Study Engineered Sialylation of Pathogenic Antibodies 707 In Vivo Attenuates Autoimmune Disease Hemagglutinin stalk 710 antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal 711 H1N1 viruses Highly pathogenic avian influenza A/Guangdong/17SF003/2016 is 714 immunogenic and induces cross-protection against antigenically divergent H7N9 viruses Effect of 717 Maternal Influenza Vaccination on Hospitalization for Respiratory Infections in Newborns: A 718 Retrospective Cohort Study Cutting edge: IL-10-producing regulatory B cells in early human 721 pregnancy Total plasma N-glycome 723 changes during pregnancy Safety and immunization during pregnancy Maternal Immunization: Nature Meets Nurture', Front Microbiol Towards a universal influenza vaccine: 729 different approaches for one goal Declining 731 responsiveness to influenza vaccination with progression of human pregnancy Pregnancy 733 modifies the antibody response to trivalent influenza immunization Endocrine factors modulating immune 735 responses in pregnancy Changes in antigen-specific IgG1 Fc N-glycosylation upon 738 influenza and tetanus vaccination Pandemic 2009 influenza A(H1N1) 743 virus illness among pregnant women in the United States Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy 746 or postpartum Structure 748 of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus The role of Fc 751 gamma receptors in the activity of immunomodulatory antibodies for cancer 756 'Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: 757 A Multi-country Retrospective Test Negative Design Study The Emerging 759 Importance of IgG Fab Glycosylation in Immunity Immunoglobulin G galactosylation and sialylation are associated with 762 pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large 763 prospective cohort study Maternal immunization: where are we now and how to 766 move forward? Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy WHO recommendations on the composition of influenza virus vaccines A Perspective on the Structural and Functional Constraints for 773 Immune Evasion: Insights from Influenza Virus Immunogenicity and cross-775 reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly H3N2 Mismatch of 2014-15 Northern Hemisphere 779 Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived 780 Antigenic Maps Clinical manifestations 782 and perinatal outcomes of pregnant women with COVID-19: a systematic review and meta-analysis Update: Characteristics of Symptomatic Women 787 of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status Figure 1: Pregnancy associated differences in influenza-specific antibody titer A), group 1-and group 3-stem specific IgG (B), hemagglutination inhibition (HAI) (C) microneutralization (MN) (D) and HA-specific IgG avidity (E) in pregnant and non-pregnant women Data represent log transformed individual datapoints and geometric mean titers (bars). ELISA, HAI and 797 MN titers were compared using one-tailed Mann-Whitney test. Avidity was evaluated using a two-tailed 798 test *p<0.05, **p<0 Figure 3: Pregnancy alters antibody Fc and Fab glycosylation Antibody glycosylation for HA-specific and bulk antibodies was analyzed by capillary electrophoresis Radar plots depicting different glycosylation profiles of bulk IgG Fc (A) and Fab (B) IgG Fc (C) and Fab (E) and H3-specific IgG Fc (D) and Fab (E) in non-pregnant and pregnant groups S=sialic acid (1-2). G-V. These dot-line and 819 stacked-bar plots depict the differences in HA1-specific antibody Fc (G-J) and Fab (O-R) and HA3-820 specific antibody Fc (K-N) and Fab (S-V) glycosylation between non-pregnant (NP) and pregnant (P) 821 women. (W, X) Heatmaps showing the spearman correlation between HA-specific Fab and Fc 822 glycosylation for pregnant (W) and non-pregnant (X) women. Significance for radar plots and 823 glycosylation determined by Mann-Whitney test Antigen-specific non-neutralizing antibody functions are affected by pregnancy Influenza H1-and H3-specific antibody dependent neutrophil phagocytosis (ADNP) (A), monocyte 828 phagocytosis (ADCP) (B), complement deposition (ADCD) (C), NK degranulation measured as Groups were compared using 830 two-tailed Mann-Whitney Test Supplemental Figure 1: Relationship of antibody profiles and vaccination No differences were observed across the 857 antibody profiles for vaccination and un-vaccinated participants. Principle component 1 (PC1) contains 858 12% of the variance and PC2 contains 10.5% of the variance. A. Dots colored to distinguish pregnant 859 (blue dots) and non-pregnant (grey dots) women. B. Dots colored to distinguish women who received 860 seasonal influenza vaccine (pink dots) and women without clinical record of vaccination